We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Investment management firm Deerfield has acquired Ablexis, a company that has developed AlivaMab Mouse technology, which is a transgenic mouse platform for human antibody drug discovery.